{"hands_on_practices": [{"introduction": "A primary goal in metabolic engineering is to efficiently convert low-cost raw materials into high-value products. To quantify the success of any bioprocess, we use performance metrics, the most fundamental of which is yield. This practice focuses on calculating the overall product mass yield ($Y_{P/S}^{m}$), a crucial parameter that tells us how many grams of product are generated from each gram of substrate consumed, providing a direct measure of process efficiency. [@problem_id:2045163]", "problem": "In a metabolic engineering project, a strain of *Klebsiella pneumoniae* has been engineered to produce 1,3-propanediol ($C_3H_8O_2$) from glycerol ($C_3H_8O_3$) as the primary carbon source. A batch fermentation is conducted in a bioreactor. The process is initiated with a culture medium containing 200.0 g of pure glycerol. After the glycerol is fully consumed by the microorganisms, the fermentation is stopped. Subsequent downstream processing and purification steps successfully recover 75.0 g of 1,3-propanediol.\n\nCalculate the overall product mass yield for this process. The product mass yield is defined as the mass of the final product recovered divided by the mass of the initial substrate consumed. Express your answer as a decimal value rounded to three significant figures.", "solution": "Define the overall product mass yield as the ratio of the mass of product recovered to the mass of substrate consumed. Let $m_{P,\\mathrm{rec}}$ be the recovered product mass and $m_{S,\\mathrm{cons}}$ be the consumed substrate mass. By definition,\n$$\nY_{P/S}^{m}=\\frac{m_{P,\\mathrm{rec}}}{m_{S,\\mathrm{cons}}}.\n$$\nGiven that all the initial substrate is consumed, we have $m_{S,\\mathrm{cons}}=m_{S,0}$. Substituting the given values,\n$$\nY_{P/S}^{m}=\\frac{75.0}{200.0}.\n$$\nCarrying out the division and rounding to three significant figures,\n$$\nY_{P/S}^{m}=0.375.\n$$", "answer": "$$\\boxed{0.375}$$", "id": "2045163"}, {"introduction": "While experimental yield tells us what a process *did* achieve, metabolic engineers must also understand the theoretical limits of what a process *can* achieve. By applying the law of conservation of mass to metabolic reactions, we can calculate the maximum theoretical yield. This exercise challenges you to use elemental balances for carbon, hydrogen, and oxygen to determine the stoichiometric maximum molar yield for an engineered pathway with a defined product ratio, a core skill for designing and evaluating novel metabolic routes. [@problem_id:2045181]", "problem": "A synthetic biology startup is developing an engineered strain of *Saccharomyces cerevisiae* for producing a specific blend of biofuels and chemical precursors. This engineered yeast anaerobically ferments glucose ($C_6H_{12}O_6$) to produce ethanol ($C_2H_5OH$) and acetic acid ($CH_3COOH$). Carbon dioxide ($CO_2$) is the only other product of this fermentation process.\n\nThrough metabolic flux analysis, it has been determined that the yeast is engineered to produce ethanol and acetic acid in a fixed molar ratio. Specifically, for every 2 moles of acetic acid produced, 7 moles of ethanol are produced.\n\nAssuming that the fermentation process proceeds with 100% conversion of glucose to these products, calculate the maximum theoretical molar yield of ethanol from glucose for this specific strain. Your answer should be a numerical value representing the moles of ethanol produced per mole of glucose consumed. Round your final answer to three significant figures.", "solution": "Let one mole of glucose be consumed. Denote the molar amounts of ethanol, acetic acid, and carbon dioxide produced as $E$, $A$, and $C$, respectively. The engineered ratio is $E:A=7:2$, i.e., $E=\\frac{7}{2}A$.\n\nAssuming only $C_{2}H_{5}OH$, $CH_{3}COOH$, and $CO_{2}$ are formed, impose elemental balances on C, H, and O:\n\nCarbon balance:\n$$6=2E+2A+C.$$\n\nHydrogen balance:\n$$12=6E+4A.$$\n\nOxygen balance:\n$$6=E+2A+2C.$$\n\nUse the fixed ratio $E=\\frac{7}{2}A$ to eliminate $E$. From the hydrogen balance,\n$$12=6\\left(\\frac{7}{2}A\\right)+4A=21A+4A=25A \\quad \\Rightarrow \\quad A=\\frac{12}{25}.$$\nHence\n$$E=\\frac{7}{2}\\cdot \\frac{12}{25}=\\frac{42}{25}.$$\nDetermine $C$ from the carbon balance:\n$$6=2E+2A+C=2\\cdot \\frac{42}{25}+2\\cdot \\frac{12}{25}+C=\\frac{108}{25}+C \\quad \\Rightarrow \\quad C=6-\\frac{108}{25}=\\frac{42}{25}.$$\nCheck the oxygen balance:\n$$E+2A+2C=\\frac{42}{25}+2\\cdot \\frac{12}{25}+2\\cdot \\frac{42}{25}=\\frac{150}{25}=6,$$\nso all balances are satisfied.\n\nWith $100$ percent conversion and fixed product ratio, the ethanol yield is determined stoichiometrically as $E=\\frac{42}{25}$ moles ethanol per mole glucose. Rounded to three significant figures, this is $1.68$.", "answer": "$$\\boxed{1.68}$$", "id": "2045181"}, {"introduction": "A metabolic pathway that appears viable based on stoichiometry may fail catastrophically inside a living cell. This is because metabolic pathways are not isolated reaction chains; they are deeply embedded within a complex network that must support all functions of life, including growth and maintenance. This conceptual problem explores the critical, and often overlooked, amphibolic nature of central metabolism, where pathways serve both to break down nutrients (catabolism) and to supply essential building blocks for biomass (anabolism). Understanding why a seemingly logical gene knockout strategy might be lethal is a vital lesson in holistic pathway design. [@problem_id:2045127]", "problem": "An aspiring metabolic engineer aims to produce a high-value polyketide, which is synthesized from acetyl-CoA, in an *Escherichia coli* strain. To maximize the carbon flux from acetyl-CoA towards the polyketide, the engineer proposes a strategy to completely knock out the gene for citrate synthase (`gltA`), the enzyme that catalyzes the first committed step of the Tricarboxylic Acid (TCA) cycle (acetyl-CoA + oxaloacetate â†’ citrate). The engineered strain is to be grown aerobically in a minimal medium where glucose is the sole carbon source. Which of the following describes the most critical reason why this strategy is likely to fail, leading to little or no production of the target polyketide?\n\nA. The knockout of citrate synthase would be lethal because it prevents the regeneration of NAD+ required for glycolysis to continue.\n\nB. The accumulation of acetyl-CoA would become toxic to the cell, triggering a global stress response that shuts down all protein synthesis.\n\nC. The strategy would fail to divert significant flux because alternative pathways, such as the glyoxylate shunt, would fully compensate for the loss of the TCA cycle.\n\nD. The disruption of the TCA cycle would block the synthesis of essential metabolic precursors, such as alpha-ketoglutarate, which are required for the production of several amino acids and other vital biomolecules, thus preventing cell growth.\n\nE. The lack of TCA cycle activity would lead to a massive surplus of Adenosine Triphosphate (ATP), which would allosterically inhibit key enzymes in the polyketide synthesis pathway.", "solution": "We analyze the metabolic consequences of deleting citrate synthase (gene gltA) in Escherichia coli growing aerobically on minimal medium with glucose as the sole carbon source, with the aim of redirecting acetyl-CoA toward a polyketide.\n\nFirst, citrate synthase catalyzes the entry of acetyl-CoA into the TCA cycle via the reaction\n$$\n\\text{acetyl-CoA} + \\text{oxaloacetate} \\to \\text{citrate} + \\text{CoA-SH}.\n$$\nA knockout of gltA blocks formation of citrate and therefore prevents downstream formation of isocitrate, alpha-ketoglutarate, succinyl-CoA, and oxaloacetate-derived flux that cycles through the TCA. The TCA cycle is amphibolic, supplying essential biosynthetic precursors. Of particular importance is alpha-ketoglutarate, the carbon skeleton for glutamate, which is the primary amino group donor for the synthesis of many amino acids and nucleotides. Without alpha-ketoglutarate synthesis from isocitrate dehydrogenase, the cell cannot produce glutamate de novo; in minimal medium lacking amino acids, this prevents biomass formation and cell growth.\n\nSecond, we check whether anaplerotic or bypass pathways can compensate. Anaplerotic carboxylation (for example via phosphoenolpyruvate carboxylase)\n$$\n\\text{PEP} + \\text{CO}_{2} \\to \\text{oxaloacetate} + \\text{Pi}\n$$\ncan supply oxaloacetate, but without citrate synthase there is no conversion of oxaloacetate and acetyl-CoA to citrate; therefore no flux can proceed to isocitrate and alpha-ketoglutarate. The glyoxylate shunt likewise cannot compensate because it requires isocitrate as substrate; with citrate synthase deleted, there is no citrate to isomerize to isocitrate, so the shunt cannot operate to produce malate while bypassing decarboxylation. Thus, alternative pathways do not restore alpha-ketoglutarate production.\n\nThird, we assess whether NAD^{+} regeneration blocks glycolysis. Under aerobic conditions, NADH generated by glycolysis is reoxidized via the respiratory chain:\n$$\n\\text{NADH} + \\tfrac{1}{2}\\text{O}_{2} \\to \\text{NAD}^{+} + \\text{H}_{2}\\text{O},\n$$\nwhich does not require a functional TCA cycle per se. E. coli possesses NADH dehydrogenases that feed electrons into the electron transport chain, so gltA deletion does not inherently prevent NAD^{+} regeneration for glycolysis.\n\nFourth, we consider acetyl-CoA accumulation and ATP balance. E. coli can dissipate excess acetyl-CoA via the Pta-AckA pathway to acetate under aerobic conditions, limiting acute acetyl-CoA toxicity; thus global shutdown from acetyl-CoA accumulation is not the most critical failure mode. In addition, knocking out the TCA cycle reduces, rather than increases, respiratory NADH generation and ATP yield; therefore a massive ATP surplus is not expected.\n\nPutting these together, the most critical reason the proposed strategy fails is that the gltA deletion blocks the synthesis of essential TCA-derived precursors, especially alpha-ketoglutarate (and also succinyl-CoA and others), causing auxotrophies for amino acids such as glutamate, glutamine, proline, and arginine in minimal medium. This prevents growth, which in turn prevents production of the target polyketide. Therefore, the correct choice is that disruption of the TCA cycle blocks essential biosynthetic precursor formation required for viability and growth (option D), and not NAD^{+} regeneration failure (A), complete compensation by glyoxylate shunt (C), acetyl-CoA toxicity (B), or ATP surplus (E).", "answer": "$$\\boxed{D}$$", "id": "2045127"}]}